Disposition of 1189 shares by Daniel Bensen of Tyra Biosciences at 20.0189 subject to Rule 16b-3

TYRA Stock  USD 15.63  1.20  8.32%   
About 55% of Tyra Biosciences' investors are presently thinking to get in. The analysis of overall sentiment of trading Tyra Biosciences stock suggests that some investors are interested at this time. The current market sentiment, together with Tyra Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Tyra Biosciences stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Tyra Biosciences Officer: Chief Operating Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 1189 common stock at 20.0189 of Tyra Biosciences by Daniel Bensen on 5th of March 2024. This event was filed by Tyra Biosciences with SEC on 2024-03-05. Statement of changes in beneficial ownership - SEC Form 4

Tyra Biosciences Fundamental Analysis

We analyze Tyra Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tyra Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tyra Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Earnings Per Share

Earnings Per Share Comparative Analysis

Tyra Biosciences is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

Tyra Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tyra Biosciences stock to make a market-neutral strategy. Peer analysis of Tyra Biosciences could also be used in its relative valuation, which is a method of valuing Tyra Biosciences by comparing valuation metrics with similar companies.

Peers

Tyra Biosciences Related Equities

DSGNDesign Therapeutics   7.94   
0%
100.0%
HOWLWerewolf Therapeutics   7.69   
0%
96.0%
CCCCC4 Therapeutics   7.10   
0%
89.0%
IPSCCentury Therapeutics   6.73   
0%
84.0%
MLYSMineralys Therapeutics,   4.08   
0%
51.0%
XLOXilio Development   2.80   
0%
35.0%
EWTXEdgewise Therapeutics   2.55   
0%
32.0%
MOLNMolecular Partners   2.53   
0%
31.0%
RAPTRAPT Therapeutics   2.45   
0%
30.0%
IKNAIkena Oncology   2.42   
0%
30.0%
CGEMCullinan Oncology   2.34   
0%
29.0%
STOKStoke Therapeutics   1.95   
0%
24.0%
ERASErasca   1.48   
0%
18.0%
PMVPPmv Pharmaceuticals   1.31   
0%
16.0%
GLUEMonte Rosa   0.84   
0%
10.0%
PHVSPharvaris   0.05   
1.0%
0%
CNTBConnect Biopharma   2.48   
31.0%
0%

Complementary Tools for Tyra Stock analysis

When running Tyra Biosciences' price analysis, check to measure Tyra Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tyra Biosciences is operating at the current time. Most of Tyra Biosciences' value examination focuses on studying past and present price action to predict the probability of Tyra Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tyra Biosciences' price. Additionally, you may evaluate how the addition of Tyra Biosciences to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years